Allergy Therapeutics plc AGYTF
0.15 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.15 Day range 0.15
0.11 52-week range 0.15
- YTD
- +36.36%
- 1 year
- +36.36%
- Market cap
- 949.88M
- EPS (ttm)
- -0.01
- YTD return
- +36.36%
- 1-year return
- +36.36%
- Volume
- 7.14K
- Open
- 0.15
- Previous close
- 0.15
- Day's range
- 0.15 – 0.15
- 52-week range
- 0.11 – 0.15
- Earnings date
- Feb 4, 2025
1M 0.0000 (0.00%)
Next earnings
Feb 4, 2025
Expected Feb 4, 2025. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2025 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 2, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jan 3, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| Oct 5, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| Dec 29, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
News
Boston Scientific beats second quarter expectations, raises full-year outlook 
Allergy Therapeutics reports accelerated revenue growth in its second half 
Allergy Therapeutics reports accelerated revenue growth in its second half 
Allergy Therapeutics names Helge Weiner-Trapness as executive chair 
Allergy Therapeutics names Helge Weiner-Trapness as executive chair 
FTSE 100 Live: London stocks surge, Wall St volatile as SpaceX trading nears 
Allergy Therapeutics to showcase pollen and food allergy progress 
Allergy Therapeutics to showcase pollen and food allergy progress 
Amazon and Delta announce agreement to offer improved in-flight Wifi 
Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker
Your note
Sign in to keep a note on AGYTF — it syncs with the Stock Master app.